Accessed 01/08/2026 at Wharton, S., Freitas, P., Hjelmesth, J., Kabisch, M., Kandler, K., Lingvay, I., Quiroga, M., Rosenstock, J., Garvey, W
These benefits can further motivate patients to continue with their treatment plan and engage in other components of it, leading to sustained weight loss and overall health improvements
Midi Health Weight Loss Review Peggy B
The SURPASS clinical trial program, which evaluated tirzepatide for type 2 diabetes over periods extending to 52 weeks and beyond, demonstrated sustained glycemic improvements without evidence of significant tachyphylaxis (rapid tolerance development) for the primary glucose-lowering effects
At Set Point Medical Weight Loss Clinic, we prioritize your safety and well-being